Genelux (GNLX) Profit After Tax (2022 - 2026)

Genelux's (GNLX) quarterly Profit After Tax came in at -$8.9 million in Q1 2026, down 18.8% year-on-year from -$11.0 million in Q1 2025, and up 3.87% quarter-over-quarter from -$9.3 million in Q4 2025.

Genelux (GNLX) Profit After Tax (2022 - 2026) Analysis & Trends

Genelux's Profit After Tax history runs 5 years deep, the most recent figure standing at -$8.9 million for Q1 2026.

  • On a quarterly basis, Profit After Tax fell 18.8% year-over-year to -$8.9 million in Q1 2026; TTM through Mar 2026 was -$33.6 million, a 14.61% decrease from a year earlier, with the FY2025 full-year figure at -$32.2 million, down 7.98% from the prior year.
  • Profit After Tax grew to -$8.9 million in Q1 2026 per GNLX's latest filing, from -$9.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $4.9 million in Q3 2022 and bottomed at -$10.4 million in Q1 2023.
  • The 5-year median for Profit After Tax is -$7.5 million (2025), against an average of -$6.5 million.
  • Across the five-year window, Profit After Tax plunged 208.88% in 2023 and climbed 24.26% in 2024, its largest moves.
  • Year by year, Profit After Tax stood at -$3.5 million in 2022, then sank by 93.62% to -$6.8 million in 2023, then plunged by 31.9% to -$8.9 million in 2024, then declined by 4.21% to -$9.3 million in 2025, then gained by 3.87% to -$8.9 million in 2026.
  • Per Business Quant, the three latest GNLX Profit After Tax figures stand at -$8.9 million (Q1 2026), -$9.3 million (Q4 2025), and -$8.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -36.84 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -26.94 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -453.82 Mn
10 Genelux 129.36 Mn 129.36 Mn - -8.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.94 Mn
Dec 31, 2025 -9.30 Mn
Sep 30, 2025 -7.95 Mn
Jun 30, 2025 -7.46 Mn
Mar 31, 2025 -7.53 Mn
Dec 31, 2024 -8.93 Mn
Sep 30, 2024 -6.33 Mn
Jun 30, 2024 -6.58 Mn
Mar 31, 2024 -7.85 Mn
Dec 31, 2023 -6.77 Mn
Sep 30, 2023 -5.35 Mn
Jun 30, 2023 -5.82 Mn
Mar 31, 2023 -10.36 Mn
Dec 31, 2022 -3.50 Mn
Sep 30, 2022 4.91 Mn